Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Lifestyle in NASH
NCT01623024Phase 3Unknown
- Sponsor
- University of Palermo
- Start
- Sep 2012
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in Nonalcoholic steatohepatitis (NASH) (2 arms), sponsored by University of Palermo. Primary endpoint: NAFLD Activity Score improvement at 96 weeks. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01623024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623024.